TrialNature communications2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
Priscilla K Brastianos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
63 papers cite itlatest 60 shown
this paperpooled ittrialcites it